Key result
Higher mean inpatient blood glucose values increased the risk for symptomatic vasospasm after subarachnoid hemorrhage (RR 1.01; 95% CI 1.0-1.03; p=0.04).
Why the study?
Does hyperglycemia increase the risk of symptomatic vasospasm and poor clinical outcomes in patients with aneurysmal subarachnoid hemorrhage?
Observational (n=352)
Does hyperglycemia increase the risk of symptomatic vasospasm and poor clinical outcomes in patients with aneurysmal subarachnoid hemorrhage?
Relative Risk: 1.01 (95% CI 1–1.03)
p-value: p=0.04
Higher mean inpatient blood glucose levels are associated with an increased risk of symptomatic vasospasm and poorer clinical outcomes following aneurysmal subarachnoid hemorrhage.
No takes yet. Share an insight, caveat, or question.
Hyperglycemia monitoring may be prudent post-SAH; leaves open whether glycemic control reduces vasospasm risk.
Badjatia et al. (2005) conducted an observational in aneurysmal subarachnoid hemorrhage (n=352). Higher mean inpatient blood glucose vs. Lower mean inpatient blood glucose was evaluated on symptomatic vasospasm (VSP) (RR 1.01, 95% CI 1.0-1.03, p=0.04). Higher mean inpatient blood glucose values increased the risk for symptomatic vasospasm after subarachnoid hemorrhage (RR 1.01; 95% CI 1.0-1.03; p=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: